Effects of physical exercise on beta cells of the pancreas: a systematic review
Silva Filho, Edson Meneses da; Albuquerque, Jéssica Andrade de ; Cacho, Roberta de Oliveira; Freitas, Rodrigo Pegado de Abreu
Background: Diabetes mellitus is a chronic disease that is rising in many parts of the world causing damage to functionality, quality of life and public health system. Objective: Verify the effects of physical exercise on beta cells of the pancreas in diabetic subjects. Methods: The database Cochrane Library via Wiley – CENTRAL, Pubmed, LILACS, SCIELO, Web of Science, Scopus, CINAHL were used to search the articles. The descriptors and synonyms of this topic were used in the search strategy. Controlled randomized clinical trials and quasi-randomized studies, which included in their samples diabetic humans undergone any type of physical exercise were included. The Cochrane collaboration bias risk tool was used to assess the risk of bias. Results: A total of 3.133 articles were initially identified and after reading the titles/abstracts and the full text 6 articles were selected for the qualitative evaluation. Most of the studies showed positive results of physical exercise on pancreatic beta cells, insulin secretion, insulin resistance and insulin sensitivity. The main limitations were the number of studies, few, and their methodological qualities. Conclusions: Physical exercises have beneficial effects on pancreatic beta cells, insulin resistance and insulin sensitivity; however better studies designs, with fewer biases and larger samples are needed so that the results presented do not be overestimated. This review is recorded in the Prospective Register of Systematic Reviews with registration number 42017054213
1. Iser B, Stopa S, Chueiri P, Szwarcwald C, Malta D, Monteiro H, et al. Prevalência de diabetes autorreferido no Brasil: resultados da Pesquisa Nacional de Saúde 2013. Epidemiol. Serv. Saúde. 2015;24(2):305-314.
2. International Diabetes Federation [Internet]. [cited 2017 Aug 4]. Available from: http://www.idf.org.
3. Unger RH. Glucagon physiology and pathophysiology. New Engl Journal Med. 1971;19; 285(8):443–449.
4. Vasques CJ, Pereira PF, Gomide RM, Batista MC, Campos MT, Sant’ana LF, et al. Influência do excesso de peso corporal e da adiposidade central na glicemia e no perfil lipídico de pacientes portadores de diabetes mellitus tipo 2. Arq. Brás. Endocrinol. Metab. 2007;51(9):1516-1521.
5. Solomon TP, Malin SK, Karstoft K, Kashyap SR, Haus JM, Kirwan JP. Pancreatic β -cell function is a stronger predictorof changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. Journal Clin Endocrinol Metab. 2013;98(10):4176-86.
6. Christensen CS, Lundh M, Dahllöf MS, Haase TN, Velasquez JM, Laye MJ, et al. Skeletal muscle to pancreatic cell cross-talk: the effect of humoral mediators liberated by muscle contraction and acute exercise on cell apoptosis. Journal Clin Endocrinol Metab. 2015;100(10):1289-1298.
7. Wagner H, Alvarsson M, Mannheimer B, Degerblad M, Östenson CG. No effect of high-dose vitamin d treatment on β-cell function, insulin sensitivity, or glucose homeostasis in subjects with abnormal glucose tolerance: a randomized clinical trial. Diabetes Care. 2016;39(3):345-52.
8. Merovci A, Abdul-Ghani M, Mari A, Solis-Herrera C, Xiong J, Daniele G, et al. Effect of dapagliflozin with and without acipimox on insulin sensitivity and insulin secretion in T2DM males. J Clin Endocrinol Metab. 2016;101(3):1249-1256.
9. Mari A, Rosenstock J, Ma X, Li YG, Jackson JA. Optimized human regular U-500 insulin treatment improves β-cell function in severely insulinresistant patients with long-standing type 2 diabetes and high insulin requirements. Endocr Pract. 2015;21(12):1344-1352.
10. Zhu Y, Li AM, Au CT, Kong AP, Zhang J, Wong CK, et al. Association between sleep architecture and glucose tolerance in children and adolescents. J Diabetes. 2015;7(1):10-15.
11. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269.
12. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Wiley. 2008:187-241.
13. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004;47:943–956.
14. Kahn SE, Prigeon RL, McCulloch DK. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663–1672.
15. Campbell RK. Fate of the beta-cell in the pathophysiology of type 2 diabetes. J Am Pharm Assoc. 2009;49(1):10-15.
16. Rutters F, Besson H, Walker M, Mari A, Konrad T, Nilsson PM, et al. The Association Between Sleep Duration, Insulin Sensitivity, and b-Cell Function: The EGIR-RISC Study. J Clin Endocrinol Metab. 2016;101(9):3272- 80.
17. Alkhalidy H, Moore W, Zhang Y, McMillan R, Wang A, Ali M, et al. Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic 𝛽 -Cell Mass in Middle-Aged Obese Diabetic Mice. 2015;532984.
18. Jessica L, Lang W, Tate DF, Bond DS, Espeland MA, Wing R. Objective estimates of physical activity and sedentary time among young adults. Journal of Obesity. 2017;17:11.
19. McCarthy M, Edwardson CL, Davies MJ, Henson J, Gray L, Khunti K, et al. Change in sedentary time, physical activity, bodyweight, and hba1c in high-risk adults. Med Sci Sports Exerc. 2017;49(6):1120-1125.
20. Bartlett ST, Markmann JF, Johnson P, Korsgren O, Hering BJ, Scharp D, et al. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement. 2016;100(2):S1-44.
21. Caumo A, Perseghin G, Brunani A, Luzi L. New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method. Diabetes Care. 2006;29:2733–2734.
22. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled Trial. Diabetes; 2012; 61(11):2787-2795.
23. Holmstrup ME, Fairchild TJ, Keslacy S, Weinstock RS, Kanaley JA. Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise. Metabolism. 2014;63:510–519.
24. Wideman L, Weltman JY, Hartman ML, Veldhuis JD, Weltman A. Growth hormone release during acute and chronic aerobic and resistance exercise. Sports Med. 2012;32:987–1004.
25. Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. High intensity interval training improves glycaemic control and pancreatic β cell function of type 2 diabetes patients. PLoS ONE. 2015;10(8).
26. Lee SF, Pei D, Chi MJ, Jeng C. An investigation and comparison of the effectiveness of different exercise programmes in improving glucose metabolism and pancreatic β-cell function of type 2 diabetes patients. Int J Clin Pract. 2015;69(10):1159-70.
27. Burns N, Finucane FM, Hatunic M, Gilman M, Murphy M, Gasparro D, et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia. 2007;50:1500–1508.
28. Mackenzie R, Maxwell N, Castle P, Elliott B, Brickley G, Watt P. Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab. 2012; 97(4):546–E555.
29. Backx K, Mccann A, Wasley D, Dunseath G, Luzio S, Owens D. The effect of a supported exercise programme in patients with newly diagnosed Type 2 diabetes: a pilot study. Journal of Sports Sciences. 2011;29(6):579–586.
30. Dela F, Michael E, Mikines K, Galbo H. Physical training may enhance B -cell function in type 2 diabetes. Am J Physiol Endocrinol Metab. 2004;287:1024–1031.